PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 544 (xsd:integer)
nif:isString
  • For many years, it has been claimed that Conus peptides could have great promising therapeutic applications as novel pharmacological substances in neuroscience, because they can specifically target with high affinity and specificity neurotransmitter-gated receptors and voltage-gated or ligand-gated ion channels [19,20,21,22,23,24,25].Typical examples for treatment are neurological disorders such as ischemia, spinal cord injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, chronic pain, stroke, epilepsy, and schizophrenia.
rdf:type